As of May 2026 Ultragenyx Pharmaceutical has a market cap of A$3.17 Billion. This makes Ultragenyx Pharmaceutical the world's 4634th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On May 25th, 2026 the market cap of Ultragenyx Pharmaceutical was reported to be: